Current Firm
OrbiMed Advisors
Investments
1+ companies
Focus
Biotech, Digital Health
Carter Neild is a Managing Partner at OrbiMed Advisors, a leading investment firm specializing in the healthcare and life sciences sectors. With a strategic focus on biotech, digital health, and artificial intelligence, Neild identifies and supports innovative companies poised to transform healthcare delivery and outcomes. His investment expertise spans early-stage ventures through established players seeking growth capital. Neild's track record includes notable investments that demonstrate his ability to recognize promising technologies and founding teams. Based at OrbiMed Advisors, he leverages deep industry knowledge and an extensive network to guide portfolio companies through critical growth phases. His work bridges cutting-edge science and practical healthcare applications, positioning him at the forefront of healthcare innovation investment.
Carter Neild is a Managing Partner, OrbiMed Advisors at OrbiMed Advisors, based in New York, NY.
Carter's investment focus spans Biotech, Digital Health, AI, primarily investing at the Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments include Carl L. Gordon. These investments span Biotech and Digital Health.
Carter Neild is a Managing Partner, OrbiMed Advisors at OrbiMed Advisors, based in New York, NY. Their investment focus includes Biotech, Digital Health, AI.
Carter Neild focuses on investments in Biotech, Digital Health, AI through OrbiMed Advisors. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Carter Neild's notable portfolio investments include Carl L. Gordon. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
Carter Neild is currently at OrbiMed Advisors, headquartered in New York, NY, serving as Managing Partner, OrbiMed Advisors.